Why Unilever has a 10.5% stake in this small cap drug developer
Just why does consumer goods giant Unilever (ULVR) have a 10.5% stake in small cap clinical stage drug developer Arecor Therapeutics (AREC:AIM)?The company listed on AIM in June 2021 at 226p per share after raising £20 million of...
28 April 2022